DHEA Peptide vs Octreotide
Overview
DHEA Peptide and Octreotide are both hormonal peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares DHEA Peptide and Octreotide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| DHEA Peptide | Octreotide | |
|---|---|---|
| Category | Hormonal | Hormonal |
| Regulatory status (US) | Research use only | FDA approved |
| Typical dosage | 25-50 mg | 20–30 mg (LAR formulation, IM every 4 weeks); 100–600 mcg/day in divided doses (immediate-release SC) |
| Frequency | daily | Every 4 weeks (LAR); two to four times daily (immediate-release) |
| Reported benefits | Hormone balance, energy, anti-aging | Reduction of growth hormone and IGF-1 in acromegaly, suppression of carcinoid flushing and diarrhea, control of VIPoma-associated watery diarrhea, antiproliferative effect on low-grade neuroendocrine tumors, reduction of urinary 5-HIAA biomarkers |
| Reported side effects | Possible acne, hormone fluctuations | Gallstones and biliary sludge, diarrhea, nausea, abdominal discomfort, sinus bradycardia, hyperglycemia, hypoglycemia, hypothyroidism, steatorrhea, injection-site pain |
Key differences
Primary use. DHEA Peptide is categorised under Hormonal, while Octreotide falls under Hormonal. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. DHEA Peptide: not FDA-approved; treated as a research compound. Octreotide: FDA-approved.
Dosing. DHEA Peptide is typically dosed at 25-50 mg (daily). Octreotide is typically dosed at 20–30 mg (LAR formulation, IM every 4 weeks); 100–600 mcg/day in divided doses (immediate-release SC) (Every 4 weeks (LAR); two to four times daily (immediate-release)).
Can you stack them?
Some protocols combine peptides, but stacking DHEA Peptide and Octreotide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between DHEA Peptide and Octreotide?
- DHEA Peptide and Octreotide are both hormonal peptides, but they differ in mechanism, dosing, and regulatory status. DHEA Peptide is not FDA-approved; generally classified as a research compound, whereas Octreotide is FDA-approved for one or more indications.
- What is DHEA Peptide used for?
- Hormone precursor support.
- What is Octreotide used for?
- FDA-approved somatostatin analog for acromegaly, carcinoid syndrome, and VIPomas since 1988.
- Can you take DHEA Peptide and Octreotide together?
- Some users combine peptides within a single protocol, but stacking DHEA Peptide and Octreotide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is DHEA Peptide or Octreotide FDA-approved?
- DHEA Peptide is not FDA-approved; generally classified as a research compound. Octreotide is FDA-approved for one or more indications.
Read the full articles
- DHEA Peptide — full monograph: mechanism, research, dosing & references
- Octreotide — full monograph: mechanism, research, dosing & references